Taken together, the above data suggest that estrogen plays an important role in the epithelial mesenchymal transition of both type I and type II endometrial cancers, and that loss of ERα and transition to estrogen signaling through GPER may be an important step in EMT for type II cancers. The gene discussed is ESR1; the disease is cancer.